GS XJG (Tykerb 250 mg)
Generic Name: lapatinib
Pill with imprint GS XJG is Orange, Elliptical / Oval and has been identified as Tykerb 250 mg. It is supplied by GlaxoSmithKline.
Tykerb is used in the treatment of breast cancer; breast cancer, metastatic and belongs to the drug classes EGFR inhibitors, HER2 inhibitors. There is positive evidence of human fetal risk during pregnancy. Tykerb 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for GS XJG
Tykerb
- Generic Name:
- lapatinib
- Imprint:
- GS XJG
- Strength:
- 250 mg
- Color:
- Orange
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- EGFR inhibitors
HER2 inhibitors - Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- GlaxoSmithKline
- Inactive Ingredients:
- magnesium stearate
microcrystalline cellulose
povidone
sodium starch glycolate type A potato
FD&C Yellow No. 6
hypromelloses
polyethylene glycol
polysorbate 80
titanium dioxide
Note: Inactive ingredients may vary.
Other Labelers / Repackagers:
| NDC Code | Labeler / Repackager |
|---|---|
| 00078-0671 | Novartis Pharmaceuticals Corporation |
More about Tykerb (lapatinib)
- Tykerb Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 1 Review
- Drug class: EGFR inhibitors
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
